You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 46 No. 2, February 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Altered Central {alpha}2-Adrenoceptor Sensitivity in Panic Disorder

David J. Nutt, MD, PhD

Arch Gen Psychiatry. 1989;46(2):165-169.


Abstract

• The possibility that a disorder of brain {alpha}2-adrenoceptor sensitivity might contribute to the etiology of panic disorder was examined using a challenge paradigm with the {alpha}2-adrenoceptor agonist clonidine. The cardiovascular, psychological, and endocrine actions of 1.5-µg/kg clonidine hydrochloride given intravenously were assessed in 16 patients and compared with age- and sex-matched controls. Patients with panic disorder showed an increased fall in blood pressure and decreased sedative and endocrine responses as compared with controls. These results suggest that there may be subsensitivity of some, and supersensitivity of other, brain {alpha}2-adrenoceptors in panic disorder. In view of the increased cardiovascular responses seen in the present study and other reports of increased responses to the {alpha}2-adrenoceptor antagonist yohimbine, there may exist an increased lability (decreased damping) of cardiovascular control mechanisms in panic disorder. Such a dysfunction could contribute to the symptoms of panic attacks, such as dizziness, palpitations, and faintness.



Author Affiliations

From the University Department of Psychiatry, Warneford Hospital, Oxford, England. Dr Nutt is now with the Reckitt and Colman Psychopharmacology Unit, The Medical School, University Walk, Bristol, United Kingdom.


Footnotes

Accepted for publication Jan 27, 1988.

Reprint requests to Reckitt and Colman Psychopharmacology Unit, The Medical School, University Walk, Bristol, United Kingdom BS8 1TD (Dr Nutt).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Does the Brain Noradrenaline Network Mediate the Effects of the CO2 Challenge?
Bailey et al.
J Psychopharmacol 2003;17:252-259.
ABSTRACT  

Does the Brain Noradrenaline Network Mediate the Effects of the CO2 Challenge? Reply to Reviewers' Comments
Bailey et al.
J Psychopharmacol 2003;17:267-268.
 

Yohimbine Challenge in Children With Anxiety Disorders
Sallee et al.
Am. J. Psychiatry 2000;157:1236-1242.
ABSTRACT | FULL TEXT  

ALCOHOL-DEPENDENT PATIENTS WITH NEUROENDOCRINE EVIDENCE FOR REDUCED DOPAMINE D2 RECEPTOR FUNCTION HAVE DECREASED PLATELET MONOAMINE OXIDASE-B ACTIVITY
Berggren et al.
Alcohol Alcohol 2000;35:210-211.
FULL TEXT  

PSYCHOPATHOLOGY IN ALCOHOL WITHDRAWAL: RELATIONSHIP TO {alpha}2-ADRENOCEPTOR FUNCTION
Fahlke et al.
Alcohol Alcohol 1999;34:750-759.
ABSTRACT | FULL TEXT  

Decreased Brain GABAA-Benzodiazepine Receptor Binding in Panic Disorder: Preliminary Results From a Quantitative PET Study
Malizia et al.
Arch Gen Psychiatry 1998;55:715-720.
ABSTRACT | FULL TEXT  

Clinical Improvement With Fluoxetine Therapy and Noradrenergic Function in Patients With Panic Disorder
Coplan et al.
Arch Gen Psychiatry 1997;54:643-648.
ABSTRACT  

Use of a dietary manipulation to deplete plasma tyrosine and phenylalanine in healthy subjects
Sheehan et al.
J Psychopharmacol 1996;10:231-234.
ABSTRACT  

BAP/SKB Young Psychopharmacologist Award Towards a neuroendocrinology of obsessive-compulsive disorder
Lucey
J Psychopharmacol 1994;8:250-257.
ABSTRACT  

Clomipramine and initial worsening in panic disorder: beyond the 'jitteriness syndrome'
Ramos et al.
J Psychopharmacol 1993;7:265-269.
ABSTRACT  

Co-existence of panic disorder and sleep paralysis
Allen and Nutt
J Psychopharmacol 1993;7:293-294.
ABSTRACT  

Platelet {alpha}2-adrenoreceptors in depression: a critical examination
Grossman et al.
J Psychopharmacol 1993;7:4-18.
ABSTRACT  

Blunted Growth Hormone Response to Clonidine in Patients With Generalized Anxiety Disorder
Abelson et al.
Arch Gen Psychiatry 1991;48:157-162.
ABSTRACT  

Imipramine in panic disorder. 1. Clinical response and pharmacological changes
Nutt and Glue
J Psychopharmacol 1991;5:56-64.
ABSTRACT  

Imipramine in panic disorder. 2. Effects on {alpha}2-adrenoceptor function
Nutt and Glue
J Psychopharmacol 1991;5:135-141.
ABSTRACT  

Flumazenil Provocation of Panic Attacks: Evidence for Altered Benzodiazepine Receptor Sensitivity in Panic Disorder
Nutt et al.
Arch Gen Psychiatry 1990;47:917-925.
ABSTRACT  

Behavioral and Physiologic Effects of Short-term and Long-term Administration of Clonidine in Panic Disorder
Uhde et al.
Arch Gen Psychiatry 1989;46:170-177.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.